Complement and the damaging effects of cardiopulmonary bypass
- PMID: 6606084
Complement and the damaging effects of cardiopulmonary bypass
Abstract
Postoperative cardiac, pulmonary, renal and coagulation dysfunction, along with C3a levels, were studied prospectively in 116 consecutive patients undergoing open cardiac operations and 12 patients undergoing closed operations in the same time period. The level of C3a 3 hours after open operation was high (median value 882 ng X ml-1 plasma) and was related to the C3a level before cardiopulmonary bypass (CPB) (p = 0.03), the level at the end of CPB (p less than 0.0001), elapsed time of CPB (p = 0.07), and older age at operation (p less than 0.0001). It was inversely related to the cardiac output as reflected by the strength of the pedal pulses (p = 0.006). In contrast, C3a levels did not rise in patients undergoing closed operations. The probability of postoperative cardiac dysfunction after open operations (present in 27 of 116 patients) was predicted by C3a levels 3 hours after operation (p = 0.02), the CPB time (p = 0.02), and younger age (p less than 0.0001). The same risk factors pertained for postoperative pulmonary dysfunction (present in 41 of the 116 patients); renal dysfunction (present in 24 of the 116 patients) except that CPB time was not a risk factor here; abnormal bleeding (present in 21 of the 116 patients); and important overall morbidity (present in 26 of 116 patients). As regards important overall morbidity, the C3a level effect became evident at about 1,900 ng X ml-1 (a level reached by 9% of patients); the effect of increasing time of CPB became evident at about 90 minutes of CPB time; and the effect of young age became evident as age decreased from 10 to 4 years. This study demonstrates the damaging effects of CPB, relates them in part to complement activation by the foreign surfaces encountered by the blood, and supports the hypothesis that the mechanisms of the damaging effects include a whole-body inflammatory reaction.
Similar articles
-
Complement activation during cardiopulmonary bypass in infants and children. Relation to postoperative multiple system organ failure.J Thorac Cardiovasc Surg. 1993 Dec;106(6):978-87. J Thorac Cardiovasc Surg. 1993. PMID: 8246580
-
Evidence for complement activation by protamine-heparin interaction after cardiopulmonary bypass.Surgery. 1985 Sep;98(3):525-31. Surgery. 1985. PMID: 3875906
-
The association of renal dysfunction and the use of aprotinin in patients undergoing congenital cardiac surgery requiring cardiopulmonary bypass.Anesth Analg. 2009 Jul;109(1):45-52. doi: 10.1213/ane.0b013e3181a7f00a. Anesth Analg. 2009. PMID: 19535694
-
Physiologic principles and clinical sequelae of cardiopulmonary bypass.Heart Lung. 1986 Jan;15(1):34-9. Heart Lung. 1986. PMID: 3511011 Review.
-
CPB in high-risk groups: CPB in diabetics.Perfusion. 2006 Jul;21(4):235-8. doi: 10.1191/0267659106pf874oa. Perfusion. 2006. PMID: 16939118 Review. No abstract available.
Cited by
-
Development of complement therapeutics for inhibition of immune-mediated red cell destruction.Transfusion. 2005 Aug;45(2 Suppl):122S-9S. doi: 10.1111/j.1537-2995.2005.00526.x. Transfusion. 2005. PMID: 16086799 Free PMC article. Review.
-
Minimally invasive aortic valve replacement: late conversion to full sternotomy doubles operative time.Tex Heart Inst J. 2009;36(4):293-7. Tex Heart Inst J. 2009. PMID: 19693301 Free PMC article.
-
Lung injury after cardiopulmonary bypass: Alternative treatment prospects.World J Clin Cases. 2022 Jan 21;10(3):753-761. doi: 10.12998/wjcc.v10.i3.753. World J Clin Cases. 2022. PMID: 35127892 Free PMC article. Review.
-
Disconnection of Cobe SMARxT tubing from the venous outlet of the Terumo Capiox SX25RX oxygenator during cardiopulmonary bypass.J Extra Corpor Technol. 2010 Jun;42(2):153-7. J Extra Corpor Technol. 2010. PMID: 20648902 Free PMC article.
-
Increased oxygen consumption after cardiac surgery is associated with the inflammatory response to endotoxemia.Intensive Care Med. 1996 Apr;22(4):294-300. doi: 10.1007/BF01700449. Intensive Care Med. 1996. PMID: 8708165
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical
Research Materials